Abacavir and Lamivudine
- Product NDC
- 42291-115
- 11-digit product format
- 422910115
- Labeler code
- 42291
- Product ID
- 42291-115_d579634f-c06a-f153-e053-2a95a90ab7a5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Abacavir and Lamivudine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA079246
- Marketing category
- ANDA
- Marketing start
- 2018-02-21
- Marketing end
- 0000-00-00
- Substance
- ABACAVIR SULFATE; LAMIVUDINE
- Active strength
- 600 mg/1; mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 1A1 Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-115-30 | 42291011530 | 1 BOTTLE in 1 CARTON (42291-115-30) > 30 TABLET, FILM COATED in 1 BOTTLE | 1 bottle | 2018-02-21 | 0000-00-00 | No | No | Current |